Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
24.39
-0.49 (-1.97%)
Nov 17, 2025, 2:14 PM CST
Yifeng Pharmacy Chain Revenue
Yifeng Pharmacy Chain had revenue of 5.56B CNY in the quarter ending September 30, 2025, with 1.97% growth. This brings the company's revenue in the last twelve months to 24.13B, up 0.88% year-over-year. In the year 2024, Yifeng Pharmacy Chain had annual revenue of 24.06B with 6.53% growth.
Revenue (ttm)
24.13B
Revenue Growth
+0.88%
P/S Ratio
1.25
Revenue / Employee
602.96K
Employees
40,018
Market Cap
30.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.06B | 1.47B | 6.53% |
| Dec 31, 2023 | 22.59B | 2.70B | 13.59% |
| Dec 31, 2022 | 19.89B | 4.56B | 29.75% |
| Dec 31, 2021 | 15.33B | 2.18B | 16.60% |
| Dec 31, 2020 | 13.14B | 2.87B | 27.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |